172. Bull Cancer. 2018 May;105(5):502-507. doi: 10.1016/j.bulcan.2018.02.003. Epub2018 Mar 19.[Hepatocellular carcinoma: Increase in incidence or future plague?][Article in French]Raoul JL(1), Raimbourg J(2), Hiret S(2), Adhoute X(3), Senellart H(2).Author information: (1)Institut de cancérologie de l'Ouest, département d'oncologie médicale, site deNantes, boulevard J.-Monod, 44805 Saint-Herblain cedex, France. Electronicaddress: jean-luc.raoul@ico.unicancer.fr.(2)Institut de cancérologie de l'Ouest, département d'oncologie médicale, site deNantes, boulevard J.-Monod, 44805 Saint-Herblain cedex, France.(3)Hôpital Saint-Joseph, département d'hépato-gastroentérologie, 26, boulevard deLouvain, 13008 Marseille, France.Hepatocellular carcinoma is the third most frequent cause of cancer deathworldwide, particularly in Asia and Africa. Most cases complicate an underlyingliver cirrhosis due to hepatitis B or C chronic virus infection or alcoholicabuse. But, following the current epidemics of obesity and type 2 diabetes, itappears that these diseases, associated in metabolic syndrome, are responsiblefor non alcoholic fatty liver disease at risk of HCC frequently before the stage of cirrhosis. Recent hypotheses consider that in the near future, cancer deathsdue to HCC will overpass in USA those due to breast or colorectal cancers.Governments should develop policies to prevent obesity, type 2 diabetes and themetabolic syndrome as well as fight against alcoholism and hepatitis B and Cvirus infections.Copyright © 2018 Société Française du Cancer. Published by Elsevier Masson SAS.All rights reserved.DOI: 10.1016/j.bulcan.2018.02.003 PMID: 29567280  [Indexed for MEDLINE]